Conversely, it is also upregulated in patients with non-metastatic prostate cancer [25] and plays a role in cisplatin resistance in tongue squamous cell carcinoma with cisplatin sensitivity being restored upon knockdown of FIS1 [26]. This evidence concerns the gene FIS1 and metastatic prostate carcinoma.